Sequential first and second trimester screening tests: Correlation of the markers' levels in normal versus Down syndrome affected pregnancies [1]

Prenatal Diagnosis

Volumn 21, Issue 13, 2001, Pages 1175-1177

  Maymon, R ^a,b   Bergman, M ^a,c,d   Segal, S ^a   Dreazen, E ^a   Weinraub, Z ^a   Herman, A ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c BARZILAI MEDICAL CENTER   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; CONTROLLED STUDY; CORRELATION ANALYSIS; CROWN RUMP LENGTH; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LETTER; MAJOR CLINICAL STUDY; NEWBORN SCREENING; OUTCOMES RESEARCH; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING TEST; SECOND TRIMESTER PREGNANCY;

ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; ESTRIOL; FEMALE; GESTATIONAL AGE; HUMANS; NECK; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS;

EID: 0035708566     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.198     Document Type: Letter

References (17)

1. Screening for Down's syndrome: Changes in marker levels and detection rates between first and second trimester
2. Editorial. Performing screening for Down's syndrome - A search for the family's values
3. Integrating antenatal Down's syndrome screening
4. Calculating correct Down's syndrome risks
5. Early pregnancy screening for fetal aneuploidy with markers and nuchal translucency
6. Image magnification does not contribute to the repeatability of nuchal translucency caliper placing
7. Nuchal translucency audit: A novel image-scoring method
8. Combined firsttrimester nuchal translucency and second-trimester biochemical screening tests among normal pregnancies
9. The effect of nuchal translucency measurement on second trimester biochemical screening for Down's syndrome
10. First trimester nuchal translucency and second trimester serum screening for fetal Down's syndrome
11. Screening for Down syndrome in the second trimester of pregnancy
12. Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies
13. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation
14. UK multicentre project on assessment of risk of trisomy 21 by maternal age and nuchal translucency thickness at 10-14 weeks of gestation
15. Effect of firsttrimester screening nuchal translucency on second trimester maternal serum biochemistry screening for Down's syndrome
16. Combining ultrasound and biochemistry in first-trimester screening for Down syndrome
17. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters